Fund shareholders of Kymera Therapeutics Inc
ISIN US5015751044 · United States
- Fund shareholders
- 328
- Of which ETFs
- 56 272 other funds
- Value held
- 3.2B $ 14.3M SEK
- Share of capital
- 45.0 % of 83.2M shares on Jul 31, 2026
328 funds hold this company: 327 declare it in a regulatory filing, and this table serves those page by page; 1 more is read from the report its fund publishes, and is not in it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,082,159 | 173.4M $ | 0.01 % | 2.50 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 2,064,507 | 188.6M $ | 0.23 % | 2.48 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 1,946,980 | 162.2M $ | 1.27 % | 2.34 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 1,796,469 | 145.6M $ | 0.40 % | 2.16 % | as of Apr 30, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1,505,906 | 125.4M $ | 0.08 % | 1.81 % | as of Mar 31, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 1,486,128 | 123.8M $ | 0.15 % | 1.79 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 1,400,582 | 116.7M $ | 0.16 % | 1.68 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 1,389,400 | 115.7M $ | 0.17 % | 1.67 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1,039,280 | 86.6M $ | 1.16 % | 1.25 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,002,367 | 83.5M $ | 0.77 % | 1.21 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 841,854 | 70.1M $ | 0.18 % | 1.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 790,951 | 65.9M $ | 0.82 % | 0.95 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 686,061 | 57.1M $ | 0.07 % | 0.83 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 635,592 | 51.5M $ | 0.24 % | 0.76 % | as of Apr 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 626,000 | 52.1M $ | 3.28 % | 0.75 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 581,361 | 53.1M $ | 0.23 % | 0.70 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 567,116 | 46M $ | 0.14 % | 0.68 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 567,076 | 47.2M $ | 0.57 % | 0.68 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 529,900 | 48.4M $ | 0.23 % | 0.64 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 525,000 | 43.7M $ | 0.19 % | 0.63 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 521,385 | 43.4M $ | 0.53 % | 0.63 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 506,025 | 42.1M $ | 0.03 % | 0.61 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 468,547 | 39M $ | 0.32 % | 0.56 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 462,441 | 42.2M $ | 0.79 % | 0.56 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 427,717 | 35.6M $ | 0.82 % | 0.51 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price All-Cap Opportunities Fund T. Rowe Price All-Cap Opportunities Fund, Inc. | 388,442 | 32.4M $ | 0.23 % | 0.47 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 317,432 | 29M $ | 0.07 % | 0.38 % | as of Feb 28, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 316,053 | 25.6M $ | 0.30 % | 0.38 % | as of Apr 30, 2026 ↗ |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 314,000 | 25.5M $ | 0.37 % | 0.38 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 300,600 | 25M $ | 0.11 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 295,828 | 27M $ | 0.13 % | 0.36 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 294,095 | 23.8M $ | 0.51 % | 0.35 % | as of Apr 30, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 292,300 | 24.3M $ | 0.18 % | 0.35 % | as of Mar 31, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 287,200 | 23.9M $ | 0.09 % | 0.35 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 279,497 | 25.5M $ | 0.17 % | 0.34 % | as of Feb 28, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 243,586 | 22.3M $ | 0.36 % | 0.29 % | as of Feb 28, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 236,238 | 19.2M $ | 0.67 % | 0.28 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 231,700 | 18.8M $ | 0.99 % | 0.28 % | as of Apr 30, 2026 ↗ |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 226,939 | 18.4M $ | 0.63 % | 0.27 % | as of Apr 30, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 225,000 | 18.2M $ | 0.63 % | 0.27 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 221,000 | 17.9M $ | 0.36 % | 0.27 % | as of Apr 30, 2026 ↗ |
| Putnam Small Cap Growth Fund Putnam Funds Trust | 216,994 | 18.1M $ | 0.67 % | 0.26 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 215,651 | 19.7M $ | 1.35 % | 0.26 % | as of Feb 27, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 202,900 | 18.5M $ | 0.01 % | 0.24 % | as of Feb 28, 2026 ↗ |
| Global Small Capitalization Fund AMERICAN FUNDS INSURANCE SERIES | 187,147 | 15.6M $ | 0.55 % | 0.23 % | as of Mar 31, 2026 ↗ |
| AB DISCOVERY GROWTH FUND, INC. AB DISCOVERY GROWTH FUND, INC. | 186,016 | 15.1M $ | 0.56 % | 0.22 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 165,700 | 13.8M $ | 0.10 % | 0.20 % | as of Mar 31, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 161,340 | 14.7M $ | 0.70 % | 0.19 % | as of Feb 28, 2026 ↗ |
| Fidelity SAI Small-Mid Cap Momentum Index Fund Fidelity Salem Street Trust | 161,103 | 13.1M $ | 0.31 % | 0.19 % | as of Apr 30, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 157,460 | 12.8M $ | 0.30 % | 0.19 % | as of Apr 30, 2026 ↗ |
| Driehaus Small Cap Growth Fund Driehaus Mutual Funds | 156,940 | 13.1M $ | 1.14 % | 0.19 % | as of Mar 31, 2026 ↗ |
| Fidelity Balanced Fund Fidelity Puritan Trust | 149,044 | 13.6M $ | 0.02 % | 0.18 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 143,695 | 11.6M $ | 0.08 % | 0.17 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 143,196 | 13.1M $ | 0.06 % | 0.17 % | as of Feb 28, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 138,100 | 11.5M $ | 0.17 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 135,000 | 11.2M $ | 0.06 % | 0.16 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 128,948 | 10.7M $ | 0.12 % | 0.16 % | as of Mar 31, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 125,897 | 10.2M $ | 0.14 % | 0.15 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 125,059 | 10.4M $ | 0.17 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 114,600 | 10.5M $ | 0.01 % | 0.14 % | as of Feb 28, 2026 ↗ |
| JNL Multi-Manager Small Cap Growth Fund JNL Series Trust | 111,476 | 9.3M $ | 0.47 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 109,830 | 9.1M $ | 0.03 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Voya Small Cap Growth Fund Voya Equity Trust | 103,422 | 9.4M $ | 0.51 % | 0.12 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 103,300 | 8.6M $ | 0.20 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 102,000 | 9.3M $ | 0.61 % | 0.12 % | as of Feb 28, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 99,358 | 8.1M $ | 0.04 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 99,000 | 8.2M $ | 0.18 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 93,115 | 7.5M $ | 0.02 % | 0.11 % | as of Apr 30, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 93,100 | 7.8M $ | 0.19 % | 0.11 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 93,041 | 7.7M $ | 0.08 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 92,972 | 7.7M $ | 0.16 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 90,418 | 8.3M $ | 0.01 % | 0.11 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Small Cap Fund Fidelity Advisor Series I | 88,400 | 8.1M $ | 0.36 % | 0.11 % | as of Feb 28, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 87,226 | 7.3M $ | 0.38 % | 0.10 % | as of Mar 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 84,094 | 7M $ | 0.38 % | 0.10 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 81,441 | 7.4M $ | 0.16 % | 0.10 % | as of Feb 27, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 79,422 | 6.6M $ | 0.01 % | 0.10 % | as of Mar 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 76,000 | 6.3M $ | 0.63 % | 0.09 % | as of Mar 31, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 73,839 | 6.2M $ | 0.58 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Small Cap Core Fund Fidelity Concord Street Trust | 72,400 | 5.9M $ | 0.36 % | 0.09 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 70,365 | 6.4M $ | 4.66 % | 0.08 % | as of Feb 28, 2026 ↗ |
| THE HARTFORD SMALL COMPANY FUND HARTFORD MUTUAL FUNDS, INC | 69,794 | 5.7M $ | 0.85 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 68,624 | 5.6M $ | 0.14 % | 0.08 % | as of Apr 30, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 68,052 | 5.5M $ | 0.24 % | 0.08 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 66,823 | 5.6M $ | 0.36 % | 0.08 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 64,500 | 5.4M $ | 0.20 % | 0.08 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 61,124 | 5.1M $ | 0.77 % | 0.07 % | as of Mar 31, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 59,927 | 5M $ | 0.15 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 59,553 | 4.8M $ | 0.93 % | 0.07 % | as of Apr 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 54,173 | 4.9M $ | 0.08 % | 0.07 % | as of Feb 27, 2026 ↗ |
| Fidelity Fund Fidelity Hastings Street Trust | 52,700 | 4.4M $ | 0.05 % | 0.06 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 51,678 | 4.7M $ | 0.33 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Enhanced Small Cap ETF Fidelity Covington Trust | 50,241 | 4.2M $ | 0.10 % | 0.06 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 49,402 | 4M $ | 0.01 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 48,624 | 3.9M $ | 0.01 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Small Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 48,353 | 4M $ | 0.55 % | 0.06 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 48,284 | 4M $ | 0.28 % | 0.06 % | as of Mar 31, 2026 ↗ |
| MFS New Discovery Series MFS VARIABLE INSURANCE TRUST | 48,058 | 4M $ | 0.57 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Column Small Cap Select Fund Trust for Professional Managers | 46,158 | 4.2M $ | 0.24 % | 0.06 % | as of Feb 28, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 45,100 | 3.8M $ | 0.14 % | 0.05 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 4.66 % | as of Feb 28, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 3.28 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 2.08 % | as of Mar 31, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 1.76 % | as of Apr 30, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 1.74 % | as of Apr 30, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.50 % | as of Feb 28, 2026 ↗ |
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 1.46 % | as of Apr 30, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 1.39 % | as of Mar 31, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 1.35 % | as of Feb 27, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 1.27 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 326 | +46 | 37,368,607 | +19.2 % |
| 2026Q1 | 280 | +34 | 31,349,132 | +16.0 % |
| 2025Q4 | 246 | +17 | 27,025,402 | +2.7 % |
| 2025Q3 | 229 | +20 | 26,320,167 | +5.4 % |
| 2025Q2 | 209 | -17 | 24,978,847 | +3.3 % |
| 2025Q1 | 226 | -3 | 24,181,745 | -0.4 % |
| 2024Q4 | 229 | +7 | 24,277,044 | +9.0 % |
| 2024Q3 | 222 | +8 | 22,274,447 | -1.1 % |
| 2024Q2 | 214 | +9 | 22,529,228 | +36.8 % |
| 2024Q1 | 205 | -9 | 16,467,458 | -17.7 % |
| 2023Q4 | 214 | 20,020,316 |
Institutional managers
248 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 11,699,950 | 974.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 8,657,242 | 721.1M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 7,474,747 | 622.6M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6,060,847 | 504.8K $ | as of Mar 31, 2026 |
| BVF INC/IL | 5,502,710 | 458.3M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,464,997 | 455.2K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,060,876 | 421.5M $ | as of Mar 31, 2026 |
| Atlas Venture Life Science Advisors, LLC | 4,578,008 | 381.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,889,687 | 324M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 3,186,830 | 265.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,389,767 | 199M $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 1,673,275 | 139.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,645,350 | 137.1M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 1,043,583 | 86.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,023,852 | 85.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 888,409 | 74M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 888,035 | 69.1M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 875,872 | 73M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 836,759 | 69.7M $ | as of Mar 31, 2026 |
| Merck & Co., Inc. | 772,165 | 64.3M $ | as of Mar 31, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 759,848 | 63.3M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 750,000 | 62.5M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 626,925 | 52.2M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 592,879 | 49.4M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 561,170 | 46.7M $ | as of Mar 31, 2026 |
Declared shareholders of Kymera Therapeutics Inc
4 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 14.30 % | 11,681,450 | as of Mar 31, 2026 · SCHEDULE 13G |
| T. Rowe Price Investment Management, Inc. | 6.70 % | 5,460,257 | as of Mar 31, 2026 · SCHEDULE 13G |
| BIOTECHNOLOGY VALUE FUND L P and 10 others | 6.30 % | 5,237,151 | as of Jun 26, 2026 · SCHEDULE 13D |
| Wellington Management Group LLP and 2 others | 4.80 % | 3,889,687 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Kymera Therapeutics Inc". https://titelia.com/en/stocks/kymera-therapeutics-inc-US5015751044